Article
A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder.
Addiction science & clinical practice - 27 Nov 2021
Chawar Caroul, Hillmer Alannah, Sanger Stephanie, D'Elia Alessia, Panesar Balpreet, Guan Lucy, Xie Dave Xiaofei, Bansal Nandini, Abdullah Aamna, Kapczinski Flavio, Pare Guillaume, Thabane Lehana, Samaan Zainab
Abstract excerpt
BACKGROUND: Patients with opioid use disorder (OUD) display an interindividual variability in their response to medications for opioid use disorder (MOUD). A genetic basis may explain the variability in this response. However, no consensus has been reached regarding which genetic variants significantly contribute to MOUD outcomes. OBJECTIVES: This systematic review aims to summarize genome-wide significant...
Topics
Join the communities discussing this publication.